相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New medications in development for the treatment of hyperuricemia of gout
Cesar Diaz-Torne et al.
CURRENT OPINION IN RHEUMATOLOGY (2015)
Risk of Anaphylaxis with Repeated Courses of Rasburicase: A Research on Adverse Drug Events and Reports (RADAR) Project
Katherine C. Allen et al.
DRUG SAFETY (2015)
Impact of hyperuricaemia on the chronic kidney disease-associated risk factors in a community-based population
Yoshiko Tsumuraya et al.
NEPHROLOGY (2015)
Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies
Matthew J. Roughley et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Cost-Effectiveness Analysis of Allopurinol Versus Febuxostat in Chronic Gout Patients: A US Payer Perspective
Pranav K. Gandhi et al.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY (2015)
Impact of allopurinol on risk of myocardial infarction
L. Grimaldi-Bensouda et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Uric Acid Levels, Kidney Function, and Cardiovascular Mortality in US Adults: National Health and Nutrition Examination Survey (NHANES) 1988-1994 and 1999-2002
Michelle C. Odden et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
SAT0356 The Therapeutic Efficacy of the Novel Uricosuric Agent UR-1102 for Hyperuricemia and Gout
S. O. Ahn et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Mechanism of Action of Colchicine in the Treatment of Gout
Nicola Dalbeth et al.
CLINICAL THERAPEUTICS (2014)
Febuxostat: drug review and update
Harmanjot K. Grewal et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2014)
Comorbidities in Patients with Crystal Diseases and Hyperuricemia
Sebastian E. Sattui et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2014)
Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia
Roy Fleischmann et al.
RHEUMATOLOGY (2014)
Up-titration of allopurinol in patients with gout
Claudine G. Jennings et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
Treatment of Asymptomatic Hyperuricemia for the Prevention of Gouty Arthritis, Renal Disease, and Cardiovascular Events: A Systematic Literature Review
Ophir Vinik et al.
JOURNAL OF RHEUMATOLOGY (2014)
Methemoglobinemia and hemolysis in a patient with G6PD deficiency treated with rasburicase
Mohamad Bassam Sonbol et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
RDEA3170, A NOVEL, HIGH AFFINITY URAT1 INHIBITOR BINDS TO A CENTRAL DOMAIN WITHIN URAT1
J. N. Miner et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
BCX4208, A NOVEL ENZYME INHIBITOR FOR CHRONIC MANAGEMENT OF GOUT, SHOWS A LOW RISK OF POTENTIAL DRUG-DRUG INTERACTIONS
S. Bantia et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
New Therapies for Gout
Daria B. Crittenden et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies
Eyal Grunebaum et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Clinical Risk Factors for Adverse Events in Allopurinol Users
Hee Jung Ryu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008
Yanyan Zhu et al.
AMERICAN JOURNAL OF MEDICINE (2012)
Safety of Urate-Lowering Therapies Managing the Risks to Gain the Benefits
Robert T. Keenan
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2012)
2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
Dinesh Khanna et al.
ARTHRITIS CARE & RESEARCH (2012)
Prevalence of Gout and Hyperuricemia in the US General Population The National Health and Nutrition Examination Survey 2007-2008
Yanyan Zhu et al.
ARTHRITIS AND RHEUMATISM (2011)
Difficult-to-Treat Gouty Arthritis A Disease Warranting Better Management
Naomi Schlesinger
DRUGS (2011)
Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Safety and Efficacy of Febuxostat Treatment in Subjects with Gout and Severe Allopurinol Adverse Reactions
Saima Chohan
JOURNAL OF RHEUMATOLOGY (2011)
JAPANESE GUIDELINE FOR THE MANAGEMENT OF HYPERURICEMIA AND GOUT: SECOND EDITION
Hisashi Yamanaka
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2011)
Hyperuricemia and Incident Hypertension: A Systematic Review and Meta-Analysis
Peter C. Grayson et al.
ARTHRITIS CARE & RESEARCH (2011)
Contemporary epidemiology of gout in the UK general population
Lucia Cea Soriano et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Epidemiology of gout: An update
E. U. R. Smith et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2010)
A prescription for lifestyle change in patients with hyperuricemia and gout
Hyon K. Choi
CURRENT OPINION IN RHEUMATOLOGY (2010)
Risk Factors Associated With Renal Lithiasis During Uricosuric Treatment of Hyperuricemia in Patients With Gout
Fernando Perez-Ruiz et al.
ARTHRITIS CARE & RESEARCH (2010)
The urate-lowering Efficacy and Safety of Febuxostat in the Treatment Hyperuricemia of Gout: The CONFIRMS trial
C. Dejaco et al.
JOURNAL FUR MINERALSTOFFWECHSEL (2010)
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Michael A. Becker et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Hyperuricemia and Risk of Stroke: A Systematic Review and Meta-Analysis
Seo Young Kim et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Novel therapies for treatment of gout and hyperuricemia
Robert Terkeltaub
ARTHRITIS RESEARCH & THERAPY (2009)
Adherence with urate-lowering therapies for the treatment of gout
Leslie R. Harrold et al.
ARTHRITIS RESEARCH & THERAPY (2009)
A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout
Jeannie Chao et al.
Current Rheumatology Reports (2009)
PEG-uricase in the management Of treatment-resistant gout and hyperuricemia
Merry R. Sherman et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
A benefit-risk assessment of benzbromarone in the treatment of gout - Was its withdrawal from the market in the best interest of patients?
Ming-Han H. Lee et al.
DRUG SAFETY (2008)
Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension - A randomized trial
Daniel I. Feig et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans
Naohiko Anzai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel
Sitna Halevy et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
SLC2A9 Is a High-Capacity Urate Transporter in Humans
Mark J. Caulfield et al.
PLOS MEDICINE (2008)
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005
L. Annemans et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: The third national health and nutrition examination survey
Jee Woong J. Choi et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans
J. A. Singh et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
British Society for Rheumatology and British Health Professionals in rheumatology guideline for the management of gout
Kelsey M. Jordan et al.
RHEUMATOLOGY (2007)
EULAR evidence based recommendations for gout.: Part II:: Management.: Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT)
W. Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Rasburicase treatment in severe tophaceous gout: a novel therapeutic option
J. D. Moolenburgh et al.
CLINICAL RHEUMATOLOGY (2006)
Febuxostat compared with allopurinol in patients with hyperuricemia and gout
MA Becker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Obesity, weight change, hypertension, diuretic use, and risk of gout in men - The health professionals follow-up study
HK Choi et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
SL Hung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
RJ Johnson et al.
HYPERTENSION (2003)
A role for uric acid in the progression of renal disease
DH Kang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism
M Mazzali et al.
HYPERTENSION (2001)
分享论文
